KARYOPHARM THERAPEUTICS INC
CUSIP 48576UAA4
Karyopharm Therapeutics Inc has 10 institutional holders in Filings Flow’s 13F database, together reporting 156.79M shares worth $60M as of Q4 2022. The largest reported holders are Affinity Asset Advisors, LLC, Opaleye Management Inc., and Exome Asset Management LLC.
Institutional Holders
10
Q4 2022
Reported Value
$60M
Ticker
unmapped
private placement or foreign
Quarters Tracked
3
Ownership Trend
Institutional holders
Total reported value
Holders
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| Affinity Asset Advisors, LLC$1.9B AUM | 1.09% | $12M | 15.25M | Q3 2025 |
| Exome Asset Management LLC$193M AUM | 0.99% | $2M | 2.00M | Q3 2025 |
| Opaleye Management Inc.$759M AUM | 0.65% | $5M | 6.00M | Q3 2025 |
| BLB&B Advisors, LLC$2.4B AUM | 0.00% | $60,510 | 75.0K | Q3 2025 |
| JPMORGAN CHASE & CO$1.56T AUM | 0.00% | $74,632 | 76.0K | Q3 2025 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.